Which omega-3 is best in the UK and is it safe with medicines

13 July 2026 — Which omega-3 is best in the UK? The useful answer starts with the label, not the brand. A suitable product should state the amounts of EPA and DHA in the daily serving, identify whether the oil comes from fish or algae, give a clear use-by date and avoid presenting the total weight of “fish oil” as though it were the active omega-3 dose. A capsule marked “1,000 mg fish oil” may contain only a fraction of that amount as EPA and DHA. For most healthy adults, oily fish remains the first option: the NHS recommends at least two portions of fish a week, including one portion of oily fish, while limits apply to some groups because oily fish can contain pollutants. Supplements are mainly relevant when oily fish is rarely eaten, a vegan source is required or a clinician has identified a specific reason for treatment. They are not routinely recommended by NHS England to prevent cardiovascular disease, including in people with type 1 or type 2 diabetes. High-dose prescription omega-3 medicines are a separate category from supermarket capsules and carry additional safety warnings, including a dose-related risk of atrial fibrillation in people with cardiovascular disease or risk factors, The WP Times reports.

The more difficult questions concern medicines. Can I take omega-3 while taking tamoxifen? There is no single UK-wide rule saying that every patient on tamoxifen must avoid ordinary food sources of omega-3, but supplements should not be started without approval from the oncology team or an oncology pharmacist. NHS prescribing material used in primary care has warned that omega-3 may interact with tamoxifen, while broader NHS medicines guidance repeatedly notes that supplements are not tested for interactions as thoroughly as licensed medicines. The answer is similarly cautious for Can I take omega-3 with SSRI? Omega-3 is not generally listed as a prohibited combination with medicines such as sertraline, citalopram or fluoxetine, yet SSRIs can increase bleeding tendency and concentrated fish oil may affect platelet function, particularly at higher doses or when combined with aspirin, clopidogrel, warfarin, apixaban or other anticoagulants. The practical rule is simple: food portions are usually treated differently from concentrated capsules, but anyone taking tamoxifen, an SSRI, blood-thinning treatment or several medicines should ask a pharmacist or prescriber to review the exact product and dose before taking it.

Should I take omega-3 in the UK or get it from food

The question Should I take omega-3 in the UK? is often framed as though a supplement were a routine nutritional requirement. It is not. In British guidance, the first decision is whether the diet already supplies oily fish or suitable plant and algal sources.

EPA and DHA are the long-chain omega-3 fats most closely associated with oily fish. Salmon, sardines, mackerel, herring and trout are common UK sources. ALA, another omega-3 fat, is found in walnuts, chia seeds, linseed and rapeseed oil, although the body converts only part of it into EPA and DHA.

The NHS advice on fish and shellfish nutrition is built around food rather than capsules. Adults are generally advised to eat at least two portions of fish each week, including one oily portion. Girls, women who may become pregnant, pregnant women and breastfeeding women are advised not to eat more than two portions of oily fish a week because pollutants can accumulate in the body. Other adults can eat up to four oily-fish portions weekly.

A supplement is most defensible when it fills a defined dietary gap, not when it is bought as insurance against every future illness.

A daily product may be reasonable in several circumstances:

• oily fish is rarely or never eaten;
• a vegan diet rules out fish oil and an algal EPA/DHA product is preferred;
• swallowing or food aversion makes dietary intake difficult;
• a dietitian or clinician has identified a specific nutritional need;
• a licensed omega-3 medicine has been prescribed for a defined condition.

Routine use becomes less convincing when the diet already contains oily fish, the product provides very little EPA and DHA, several overlapping supplements are being taken or the buyer expects it to prevent heart attacks, depression, dementia or cancer. NHS England states that omega-3 fatty-acid compounds should not routinely be offered for cardiovascular prevention, including to people with diabetes, chronic kidney disease or previous cardiovascular disease.

Which omega-3 is best in the UK for dose, quality and value

There is no universally best bottle. The strongest choice is the one that delivers a suitable amount of EPA and DHA, is safe with the user’s medicines and remains affordable enough to take consistently.

The front of the packet is rarely sufficient. The back label should show the amount of EPA and DHA per capsule or per daily serving. A product containing 1,000 mg of fish oil but only 180 mg EPA and 120 mg DHA provides 300 mg of the principal long-chain omega-3 fats, not 1,000 mg.

Fish-body oil and cod-liver oil are not interchangeable. Cod-liver oil can contain substantial vitamin A. The NHS warns that long-term excess vitamin A may be harmful and advises that intake from food and supplements combined should not exceed 1.5 mg a day. Pregnant women and those trying for a baby are usually told to avoid supplements containing vitamin A in the retinol form unless specifically advised by a clinician.

Algal oil is the clearest vegan alternative because it can supply DHA and sometimes EPA directly. Linseed oil supplies ALA but should not automatically be treated as an equivalent dose of EPA and DHA. Krill oil is another marine option, although its higher price does not by itself prove better absorption or better clinical results.

How much EPA and DHA should a UK product contain

For a healthy adult filling a dietary gap, products supplying a few hundred milligrams of combined EPA and DHA per day are common. That is a nutritional amount, not a prescription treatment dose.

High-dose omega-3 should not be copied from research headlines or taken to lower triglycerides without clinical supervision. Licensed omega-3-acid ethyl ester medicines used for hypertriglyceridaemia differ from ordinary food supplements in formulation, quality control, dose and medical monitoring. The MHRA announced in January 2024 that atrial fibrillation should be listed as a common adverse reaction for these medicines in patients with established cardiovascular disease or cardiovascular risk factors, with the risk increasing at higher doses.

“Before taking an omega-3-acid ethyl ester medicine, inform your doctor or pharmacist if you are currently experiencing heart problems or have a history of heart problems,” the MHRA advised in its January 2024 safety update.

Palpitations, dizziness, shortness of breath and unusual tiredness while taking a prescribed omega-3 medicine require medical advice because they may indicate an abnormal rhythm. A prescribed medicine should not be stopped without speaking to the prescriber.

Can I take omega-3 while taking tamoxifen

Tamoxifen is used in the treatment and prevention of some hormone-receptor-positive breast cancers. The safety question is not limited to whether two substances have a formally documented interaction. It also concerns bleeding, liver function, other cancer treatments, surgery, allergies and the reliability of supplement ingredients.

One NHS primary-care resource on alternatives to hormone replacement therapy states that omega-3 may interact with tamoxifen and advises avoiding it while taking the medicine. That document does not mean every British oncology service applies an identical blanket restriction, but it is strong enough to rule out casual self-prescribing.

The safer sequence is:

1. Photograph the front and back of the proposed supplement.
2. Record the daily EPA and DHA amounts and any added vitamins or botanicals.
3. Give the information to the breast-care nurse, oncology pharmacist or prescribing clinician.
4. Ask whether the advice applies to food, ordinary-dose supplements, high-dose products or all three.
5. Do not stop tamoxifen to accommodate a supplement.

Food sources of omega-3 should not be treated automatically as equivalent to concentrated capsules. Eating a normal portion of salmon is different from taking several grams of purified oil each day. An oncology team may also consider upcoming surgery, bruising, platelet count, liver results and concurrent medicines before advising.

Tamoxifen is the treatment with proven clinical purpose; omega-3 is the optional item and should be judged around that treatment.

Patients should be particularly cautious with combined “menopause support” products. These may contain herbal ingredients, phytoestrogens or high vitamin doses in addition to omega-3. The relevant question is not merely whether fish oil is acceptable but whether every ingredient in the preparation is suitable during breast-cancer treatment.

Can I take omega-3 with SSRI antidepressants

SSRIs include sertraline, citalopram, escitalopram, fluoxetine and paroxetine. Omega-3 is not routinely listed by the NHS as an absolute contraindication with these medicines, but absence from a short interaction list is not proof that every dose and product is safe.

SSRIs can impair platelet aggregation and increase the likelihood of bleeding, particularly when combined with medicines such as aspirin, ibuprofen, naproxen, warfarin, apixaban, rivaroxaban or clopidogrel. Concentrated omega-3 may also influence platelet activity. For many people, an ordinary nutritional dose may not create a clinically important problem, but risk rises when several bleeding-related factors are present.

A pharmacist should review the combination when any of the following applies:

• recurrent nosebleeds or unexplained bruising;
• a stomach ulcer or previous gastrointestinal bleeding;
• aspirin, anticoagulant or antiplatelet treatment;
• regular use of ibuprofen or naproxen;
• liver disease, low platelets or a clotting disorder;
• planned surgery, dental extraction or invasive investigation;
• a high-dose omega-3 product rather than a standard supplement.

The NHS pages for individual antidepressants advise patients to tell their doctor or pharmacist about supplements because complementary products are not evaluated for interactions in the same way as licensed medicines. That principle is more useful than relying on a generic online interaction checker that may not distinguish between 250 mg and 4 g of omega-3.

Omega-3 has been studied as an adjunct in depression, but results do not justify replacing an SSRI, changing its dose or stopping it. Abruptly discontinuing an antidepressant can cause withdrawal symptoms and relapse. Any change should be agreed with the prescriber.

Where to buy omega-3 in the UK without relying on advertising

Omega-3 is widely sold by pharmacies, supermarkets, health-food shops and online retailers. The place of purchase matters less than label quality, traceability and the ability to obtain professional advice.

Food supplements in the UK are regulated as foods rather than medicines. Manufacturers must comply with food-safety, composition and labelling rules, but supplements do not undergo the same pre-market assessment of efficacy as licensed medicines. Government guidance updated in June 2026 lists fish oils and omega-3 among common food supplements and notes that supplements can produce side effects such as nausea and headaches.

A community pharmacy is the most useful buying route when prescription medicines are involved. The pharmacist can compare the chosen product with the patient’s medication record and identify duplicated vitamin A, vitamin D or anticoagulant risk. Supermarket or online products may be perfectly adequate for someone without medical complications, provided the label is complete and the seller is reputable.

Avoid products that:

• hide EPA and DHA behind a proprietary blend;
• promise to cure or treat diagnosed disease;
• combine omega-3 with numerous herbs without clear doses;
• use subscription pressure or “detox” language;
• lack a UK contact address, batch code or durability date;
• cost substantially more without offering a higher usable EPA/DHA dose.

Price should be compared per 500 mg or 1,000 mg of combined EPA and DHA, not per bottle. A cheap bottle requiring four capsules daily can cost more per effective dose than a concentrated product taken once or twice.

What the evidence means for British consumers

Omega-3 occupies two different worlds in Britain. One is ordinary nutrition: eating oily fish, using rapeseed oil, adding walnuts or choosing an algal supplement when fish is excluded. The other is medical treatment with concentrated, licensed preparations for selected patients.

Confusion begins when evidence from one category is used to market the other. A trial involving several grams of purified EPA in high-risk patients does not prove that a low-dose supermarket capsule prevents cardiovascular disease. Equally, the fact that routine supplements are not recommended for heart-disease prevention does not mean oily fish has no place in a balanced diet.

The most reliable decision can be reduced to four questions:

1. Is oily fish already eaten regularly?
2. How much EPA and DHA does the proposed daily dose actually provide?
3. Are tamoxifen, an SSRI, anticoagulants or other relevant medicines being taken?
4. Is the goal nutritional support or treatment of a diagnosed condition?

For most healthy adults, food comes first and a modest supplement is optional rather than essential. For people taking tamoxifen, the oncology team should approve any omega-3 capsule before use. For people taking SSRIs, the combination is not automatically forbidden, but bleeding risk and other medicines must be considered. Westminster sets the regulatory framework, yet the safest individual answer is usually found at the pharmacy counter or within the clinical team that knows the patient’s treatment.

Read about the life of Westminster and Pimlico district, London and the world. 24/7 news with fresh and useful updates on culture, business, technology and city life: Westquay Bunsik launches limited BTS menu in Southampton